Categories: NewsPatient Care

Neuma Innovations’ Single-Use IV Disinfecting Cap Improves CLABSI Prevention and Deters Central Line Abuse by IVDU Patients

Neuma Develops Disinfecting Cap That Mechanically Cannot Be Used More Than Once

PALO ALTO, CA / ACCESSWIRE / July 11, 2023 / Neuma Innovations™, creator of the original Neuma Clamp™ that deters and detects central line abuse by IVDU (intravenous drug using) patients, today announced the development of a new disinfecting cap that prevents reuse and is tamper-evident.

Neuma Innovations
Neuma Innovations Logo

“We’ve been working closely with infusion professionals since 2015 to design solutions to problems associated with central line blood infections. We learned that about 28% of caregivers use the same disinfecting cap more than once, which obviously compromises the caps’ effectiveness. Our team set out to design a simple device that, because it can’t be reattached after the first use, dramatically improves compliance,” said Hal Rucker, President of Neuma Innovations. “The added benefit is that our cap also protects lines from patients who use their lines to self-inject illicit drugs.”

NO CHANGES TO WORKFLOWS

The Neuma Cap™ disinfects, approaches 100% compliance, minimizes the harmful consequences of abuse by IVDU patients, facilitates the discharge to SNF and OPAT care, and fits seamlessly into existing workflows.

“The Neuma Cap genuinely ensures the enforcement of single-use protocols while its price point remains on par with comparable alternatives,” said Amy Duncan, Director of Business Development. “The ingenuity of Neuma’s product lies in its indistinguishable resemblance to conventional disinfecting caps without requiring any changes in workflow. From the perspective of clinicians, the Neuma Cap is a frictionless industry disrupter for optimal patient care.”

About Neuma Innovations

Neuma Innovations develops simple medical products to solve complex medical problems.

Neuma Caps and Neuma Clamps are patent-protected. Neuma, Neuma Innovations, Neuma Clamp, Neuma Central Line Protection Clamp, Neuma Cap, and Neuma Disinfecting Cap are trademarks of Neuma Innovations, LLC. All Rights Reserved.

Copyright © 2023 Neuma Innovations LLC

Contact Information

Hal Rucker
President
hrucker@neumainnovations.com
(650) 759-1203

SOURCE: Neuma Innovations

View source version on accesswire.com:
https://www.accesswire.com/766774/Neuma-Innovations-Single-Use-IV-Disinfecting-Cap-Improves-CLABSI-Prevention-and-Deters-Central-Line-Abuse-by-IVDU-Patients

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

14 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

14 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

2 days ago